Results of Phase 3 trial evaluating efficacy and safety of dasiglucagon for treatment of severe hypoglycemia in adult patients with diabetes

The RCT (n=170) found that dasiglucagon administration resulted in a reversal of hypoglycaemia (with a median recovery time of 10 minutes vs 40 minutes for placebo) P < 0.001)) with 99% of trial participants reaching recovery within 15 minutes.

Biospace Inc.